Stephens Investment Management Group LLC grew its stake in shares of iRhythm Technologies, Inc. (NASDAQ:IRTC - Free Report) by 25.6% in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 502,925 shares of the company's stock after acquiring an additional 102,600 shares during the period. Stephens Investment Management Group LLC owned about 1.61% of iRhythm Technologies worth $45,349,000 at the end of the most recent quarter.
Other large investors have also recently modified their holdings of the company. R Squared Ltd bought a new stake in iRhythm Technologies during the 4th quarter valued at $45,000. KBC Group NV raised its position in shares of iRhythm Technologies by 45.1% in the 4th quarter. KBC Group NV now owns 1,319 shares of the company's stock valued at $119,000 after purchasing an additional 410 shares during the last quarter. Nisa Investment Advisors LLC lifted its stake in shares of iRhythm Technologies by 166.6% during the fourth quarter. Nisa Investment Advisors LLC now owns 1,037 shares of the company's stock worth $94,000 after buying an additional 648 shares during the period. Hennion & Walsh Asset Management Inc. grew its holdings in shares of iRhythm Technologies by 28.3% during the fourth quarter. Hennion & Walsh Asset Management Inc. now owns 4,506 shares of the company's stock valued at $406,000 after buying an additional 994 shares during the last quarter. Finally, Harbor Capital Advisors Inc. grew its holdings in shares of iRhythm Technologies by 6.3% during the fourth quarter. Harbor Capital Advisors Inc. now owns 84,947 shares of the company's stock valued at $7,660,000 after buying an additional 5,009 shares during the last quarter.
Insider Buying and Selling at iRhythm Technologies
In other iRhythm Technologies news, insider Patrick Michael Murphy sold 2,492 shares of the company's stock in a transaction dated Monday, December 2nd. The stock was sold at an average price of $85.89, for a total transaction of $214,037.88. Following the sale, the insider now owns 35,327 shares in the company, valued at $3,034,236.03. This represents a 6.59 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 0.68% of the stock is currently owned by corporate insiders.
iRhythm Technologies Trading Up 4.0 %
Shares of iRhythm Technologies stock traded up $4.28 on Wednesday, reaching $111.17. The company had a trading volume of 405,988 shares, compared to its average volume of 418,189. The company has a debt-to-equity ratio of 9.00, a quick ratio of 6.12 and a current ratio of 6.27. The firm has a market cap of $3.48 billion, a PE ratio of -22.87 and a beta of 1.29. The firm's 50 day moving average price is $97.43 and its two-hundred day moving average price is $81.88. iRhythm Technologies, Inc. has a 52-week low of $55.92 and a 52-week high of $124.11.
Wall Street Analysts Forecast Growth
A number of analysts have recently weighed in on IRTC shares. Robert W. Baird cut their price objective on shares of iRhythm Technologies from $100.00 to $79.00 and set an "outperform" rating on the stock in a research note on Friday, November 1st. Canaccord Genuity Group raised their price objective on shares of iRhythm Technologies from $125.00 to $152.00 and gave the stock a "buy" rating in a research note on Monday, December 9th. Truist Financial boosted their target price on shares of iRhythm Technologies from $85.00 to $111.00 and gave the company a "buy" rating in a research note on Wednesday, December 18th. Needham & Company LLC raised their price objective on iRhythm Technologies from $96.00 to $112.00 and gave the company a "buy" rating in a report on Monday, January 13th. Finally, Wells Fargo & Company reissued an "equal weight" rating and set a $86.00 target price on shares of iRhythm Technologies in a report on Tuesday, December 3rd. One investment analyst has rated the stock with a sell rating, two have issued a hold rating and nine have issued a buy rating to the company's stock. According to MarketBeat, iRhythm Technologies currently has an average rating of "Moderate Buy" and a consensus price target of $108.45.
View Our Latest Report on IRTC
iRhythm Technologies Profile
(
Free Report)
iRhythm Technologies, Inc, a digital healthcare company, engages in the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. It offers Zio services, an ambulatory monitoring solution, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services.
Further Reading
Before you consider iRhythm Technologies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and iRhythm Technologies wasn't on the list.
While iRhythm Technologies currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
